Investor Ideas, Trading Ideas and Stocks to Watch

Wednesday, January 06, 2021

#AIEye #Podcast 504: GBT Tokenize (OTCPINK: $GTCH) Developing Health Analysis Methods Based on Kirlian Electrophotography Research and NICE (NasdaqGS: $NICE) Introduces New #AI-Based RPA Capabilities #artificialintelligence

#AIEye #Podcast 504: GBT Tokenize (OTCPINK: $GTCH) Developing Health Analysis Methods Based on Kirlian Electrophotography Research and NICE (NasdaqGS: $NICE) Introduces New #AI-Based RPA Capabilities #artificialintelligence

Global AI in Aviation to Reach $4.67 Billion by 2027

Point Roberts WA, Vancouver BC – January 6, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/010621-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/01061GTCH-NICE.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTCPINK:GTCH) (NasdaqGS:NICE)

GBT Tokenize Corp, the joint venture of GBT Technologies Inc. (OTC PINK:GTCH), is developing new methods for health analysis based on its Kirlian Electrophotography research. Danny Rittman, GBT’s CTO, explained:

"Kirlian imaging of living tissue may exhibit energy levels that can be visualized as auras. We are now developing a set of geometrical computation methods and algorithms to graphically analyze these images further feeding the data into our machine learning programs. The target is to reach consistent and reliable conclusions with respect to the analysis of the image and any anomalies. Computational geometry is a field of computer science that is aimed to solve problems stated in terms of geometry. Here we are implementing these techniques for Kirilian images to find unique patterns. The development of these geometrical algorithms is part of our image processing long term plan and will be further used during next year for AI imaging analytics.”

NICE Ltd. (NasdaqGS:NICE) has introduced new AI-based Robotic Process Automation (RPA) capabilities “that fast-track the time to value by rapidly operationalizing optimal process automation opportunities,” which includes the new “Click to Automate” feature, that “instantaneously transforms recommended process sequences into live operational automations.” Barry Cooper, President, NICE Enterprise Group, explained:

"The new capabilities in NICE RPA version 7.4 power agility across the automation lifecycle – including intelligent, optimal process discovery, instantaneous operationalization of process automations and stronger employee collaboration. We believe this helps organizations ensure business continuity, boost their bottom line and enhance both employee and customer experiences."

Global AI in Aviation to Reach $4.67 Billion by 2027

A report published by Data Bridge Market Research finds that the global AI in Aviation market is expected to reach $4.67 billion by 2027 while exhibiting a compound annual growth rate (CAGR) of 45.8 percent in the forecast period 2020-2027. An excerpt from the report description outlines some ways AI is being employed in the market:

The use of artificial intelligence in [the] aviation industry involves the presence of the services and systems, such as baggage screening, passenger identification and maintenance, providing customer support, facial recognition, aircraft fuel optimization and more. All these functions using artificial intelligence in aviation are implemented to reduce the labour intensity [for] employees, [and] also to ensure the smooth and efficient operations without [the need for] much human intervention. [This] automation in aviation would help in increasing customer satisfaction and is efficient to handle [the] overall system.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

About GBT Technologies Inc.

GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms. GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software. GBT’s system envisions the creation of a global mesh network. The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Disclosure: GBT is a paid monthly featured company on Investorideas.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

#CryptoCorner #Podcast Episode 502: #Stocks discussed: (OTC: $TGONF) (NYSE: $IGT) (TSXV: $BNXA.V) (OTCQB: $INTV)

#CryptoCorner #Podcast Episode 502: #Stocks discussed: (OTC: $TGONF) (NYSE: $IGT) (TSXV: $BNXA.V) (OTCQB: $INTV)

#Bitcoin Briefly Breaks $36K, Ripple Sued by Tetragon Financial Group, Gambling Tech Firm IGT Awarded Patent Allowing #Crypto Betting, and BANXA Goes Public on TSX Venture Exchange

Point Roberts, WA, Delta BC, January 6, 2021 - Investorideas.com, a leader in crypto and blockchain investing news brings you today’s edition of the Crypto Corner podcast and commentary on what’s driving cryptocurrency stocks and the crypto market. Today’s podcast was sponsored by Integrated Ventures (OTCQB: INTV) , a company focused on acquiring, launching and operating assets in the cryptocurrency sector.

Listen to today’s Crypto Corner Podcast:

https://www.investorideas.com/Audio/Podcasts/2021/010621-CryptoMarket.mp3

Read this in full at https://www.investorideas.com/news/2021/crypto-corner/01061TGONF-IGT-BNXA-INTV.asp

Get the Crypto Corner Podcast on iTunes

Get the Crypto corner on Spotify

Stocks discussed: (OTC:TGONF) (NYSE:IGT) (TSXV:BNXA)

Bitcoin (BTC) scored yet another all-time high last night, climbing to a peak of roughly $36,350, according to data from CoinMarketCap. It was short-lived, however, and after about an hour above $36K it returned to around $34,000, where it has remained ever since (trading for $34,800 at press time). A recent article from NEWSBTC attributes this recent growth to bearish sentiment toward the US dollar, resulting from a Democratic Party win in the Georgia Senate election. An excerpt reads:

Investors believe that would pave the [way] for Democrats to pass more fiscal packages, beginning with a recent proposal of aiding Americans with a $2,000 stimulus check. Bitcoin traders treat federal and government spending as bearish for the dollar and bullish for their crypto holdings, citing scarcity.

Ripple’s woes continue as investment firm Tetragon Financial Group Limited (OTC:TGONF) has sued the former to “enforce its contractual right to require Ripple to redeem” Series C preferred stock held by Tetragon and to block Ripple from using any cash or other liquid assets until the payment is made,” according to an article from Bloomberg. Ripple commented:

“We are disappointed that Tetragon is seeking to unfairly take advantage of the lack of regulatory clarity here in the U.S. The courts will provide this clarity and we are very confident in our position.”

CoinDesk reports that gambling tech giant International Game Technology plc’s (NYSE:IGT) newly-awarded patent could allow for crypto-holding gamblers to pay for their bets with Bitcoin, Bitcoin Cash (BCH), and Ether (ETH). According to the report, “users of IGT’s method [outlined in the patent] would be able to transfer cryptocurrency into their gaming accounts as a means of payment. There, the crypto would convert to fiat currency after payment of a fee.”

BANXA (TSXV:BNXA), a Payment Service Provider “focused on providing clients safe, compliant access to the digital assets market,” went public today. The company’s Founder & Chairman, Domenic Carosa, said:

"It is a significant milestone to list on the TSX Venture Exchange. While 2020 and the uncertainty of COVID has been challenging to many businesses, it has also been a period of substantial growth for us. This listing is in line with our core belief that regulation and transparency provides clarity for stakeholders. Our customers want a safe, reliable partner who can give them access to the digital asset market and we provide that to them. We look forward to a successful 2021 and this listing is another step along that path."

Sam Mowers, Investorideas

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

Crypto Corner Podcast sponsor

Integrated Ventures (OTCQB: INTV) is focused on acquiring, launching and operating assets in the cryptocurrency sector.

The Crypto Corner is part of the Investor Ideas Membership content

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Cryptocurrency Disclaimer

Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800-665-0411

Get more Bitcoin and Blockchain Investor ideas – news, articles, podcasts and stock directories

#MedicalTechnology #Stock Sigyn Therapeutics (OTC: $SIGY) Reports Results of Pilot Study to Address Inflammatory CytoVesicles; @Sigyn_inc

#MedicalTechnology #Stock Sigyn Therapeutics (OTC: $SIGY) Reports Results of Pilot Study to Address Inflammatory CytoVesicles; @Sigyn_inc

Sigyn Therapy™ is a Candidate to Treat Life-Threatening Inflammatory Conditions That Are Not Addressed with Drug Therapies

SAN DIEGO CA, January 6, 2021 -- (Investorideas.com Newswire) Medical Therapeutic technology stock news - Sigyn Therapeutics, Inc. (OTCMarkets: SIGY) , a medical technology company whose focus is the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome (the Cytokine Storm), today announced the results of an in vitro pilot study that successfully modeled the ability of Sigyn Therapy™ to address CytoVesicles that transport inflammatory cytokine cargos in the bloodstream.

Read this news, featuring SIGY in full at https://www.investorideas.com/news/2021/biotech/01061SIGY-Inflammatory-CytoVesicles.asp

Cytokine Storm Syndrome is an excessive response of the immune system that is induced by infectious and non-infectious conditions. A hallmark indicator of Cytokine Storm Syndrome is the excessive or uncontrolled release of pro-inflammatory cytokines, which can lead to multiple organ failure and cause death. The annual market opportunity to address Cytokine Storm related indications exceeds $20 billion and includes sepsis, the most common cause of hospital deaths worldwide. Virus-induced Cytokine Storm Syndrome is a leading cause of death resulting from severe SARS-CoV-2 (COVID-19) infections.

Sigyn Therapy is a proprietary blood purification technology designed to overcome the limitations of previous drug and device candidates to treat acute inflammatory conditions. Incorporated within Sigyn Therapy is a cocktail of adsorbent components with unique binding and capture characteristics to optimize the broad-spectrum depletion of inflammatory targets from the bloodstream. These targets include pro-inflammatory cytokines, endotoxin and CytoVesicles (extracellular vesicles that transport inflammatory cytokine cargos) that participate in concert with freely circulating cytokines to further escalate the Cytokine Storm. CytoVesicles are an important yet previously elusive target as they can be 20-60 times larger than cytokines themselves.

In the in vitro pilot study, 104nm liposomes were utilized as a model system to assess the ability of Sigyn Therapy’s adsorbent components to deplete CytoVesicles from human blood plasma. After a two-hour interaction with Sigyn’s adsorbent components, liposome concentrations in human blood plasma were reduced ~90%. Previously published studies have validated liposomes as a model for the isolation of extracellular vesicles from blood based on the similarity of their size and structural characteristics.

“When we designed Sigyn Therapy, we envisioned a device that could be broadly deployed by the medical community, yet also have expansive first-in-industry capabilities that offer to improve patient outcomes,” stated Jim Joyce, Chairman and CEO of Sigyn Therapeutics. “When considering our previous report that Sigyn Therapy™ clears both endotoxin and inflammatory cytokines from human blood plasma, the observation from our CytoVesicle pilot study further reinforces the potential for our vision to become a therapeutic reality.”

Sigyn Therapy is a single-use device designed for use on the established infrastructure of dialysis and CRRT machines already located in hospitals and clinics worldwide. On December 1, 2020, the Company reported the results of an in vitro study that validated the ability of Sigyn Therapy to simultaneously reduce the presence of endotoxin and relevant pro-inflammatory cytokines, which included Interleukin-1 Beta (IL-1B), Interleukin-6 (IL-6) and Tumor Necrosis Factor alpha (TNF-a). Endotoxin (lipopolysaccharide or LPS) is a potent mediator implicated in the pathogenesis of sepsis and septic shock. The dysregulated over-production of IL-1B, IL-6 and TNF-a can lead to organ failure and cause death.

An objective of the study was to rebalance elevated cytokine levels and optimize the elimination of endotoxin from human blood plasma. The study was conducted in triplicate over four-hour time periods with a pediatric version of Sigyn Therapy. Average reduction of endotoxin load peaked at 83% during the studies. The average reduction of IL-1B was 69%, IL-6 reduction was 59% and TNF-a reduction was 57% during the four-hour studies.

The resulting data from each of these studies will be incorporated into an Investigational Device Exemption (IDE) that Sigyn Therapeutics plans to submit to the United States Food and Drug Administration (FDA) in 2021.

About Sigyn Therapeutics

Sigyn Therapeutics™ is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Our mission is to save lives.

Sigyn Therapy™ is a novel blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the most common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a leading cause of SARS-CoV-2 (COVID-19) deaths. Other therapeutic opportunities include, but are not limited to bacteria induced cytokine storm (BICS), acute respiratory distress syndrome (ARDS) and acute forms of liver failure, such as hepatic encephalopathy.

To learn more, visit www.SigynTherapeutics.com or www.SigynTherapy.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements of Sigyn Therapeutics, Inc. (“Sigyn”) that involve substantial risks and uncertainties. All statements contained in this press release are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The words “could,” “will,” “plan,” “intend,” “anticipate,” “approximate,” “expect,” “potential,” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among others, statements about Sigyn’s future financial performance, the impact of management changes, any proposed organizational restructuring, results of operations, capital resources to fund operations; statements about Sigyn’s expectations regarding the capitalization, resources and ownership structure of the combined company; statements about the potential benefits of the transaction; the expected completion and timing of the transaction and other information relating to the transaction; and any other statements other than statements of historical fact. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that Sigyn makes due to a number of important factors, including (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect Sigyn’s business and the price of the common stock of Sigyn, (ii) the failure to satisfy of the conditions to the consummation of the transaction, (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement, (iv) risks related to the ability to realize the anticipated benefits of the transaction, including the risk that the businesses will not be integrated successfully, (v) the effect of the announcement or pendency of the transaction on Sigyn’s business relationships, operating results and business generally, (vi) risks that the proposed transaction disrupts current plans and operations, (vii) risks related to the combined entity’s ability to up-list to a national securities exchange, (viii) risks related to the combined entity’s access to existing capital and fundraising prospects to fund its ongoing operations, (ix) risks related to diverting management’s attention from Sigyn’s ongoing business operations, (x) other business effects, including the effects of industry, market, economic, political or regulatory conditions, future exchange and interest rates, and changes in tax and other laws, regulations, rates and policies, and (xi) risks related to an inability to manufacture Sigyn Therapy, risks related to the clinical advancement of Sigyn Therapy with regulatory agencies, and no assurance that Sigyn Therapy will be proven to be a safe and efficacious treatment for any condition. The forward-looking statements in this press release represent Sigyn’s views as of the date of this press release. Sigyn anticipates that subsequent events and developments may cause its views to change. However, while it may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. You should, therefore, not rely on these forward-looking statements as representing Sigyn’s views as of any date subsequent to the date of this press release.

Contact Sigyn Therapeutics, Inc.

Jim Joyce

Chairman, CEO

(619) 368-2000

jj@sigyntherapeutics.com

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), is a paid for service on Investorideas.com . More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com lease read Investorideas.com privacy policy https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com

https://www.investorideas.com/About/

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Tuesday, January 05, 2021

#ExploringMining #Podcast Episode 131 – #Mining #Stocks News from (NYSEAmerican: $SILV) (TSX: $SIL.TO) (NYSE: $AEM) (TSX: $TMAC.TO) (TSXV: $MGM.V) (TSX: $LN.TO)

#ExploringMining #Podcast Episode 131 – #Mining #Stocks News from (NYSEAmerican: $SILV) (TSX: $SIL.TO) (NYSE: $AEM) (TSX: $TMAC.TO) (TSXV: $MGM.V) (TSX: $LN.TO)

Point Roberts WA, Delta BC, January 5, 2021 Investorideas.com, a global investor news source covering mining and metals stocks releases today’s edition of Exploring Mining Podcast, featuring stock news from TSX, TSXV ,CSE, ASX, NASDAQ, NYSE companies plus interviews with CEO's and leading experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/010521-Mining.mp3

Read this in full at https://www.investorideas.com/news/2021/exploring-mining/01051SILV-AEM-TMAC-MGM-LN.asp

Listen to Exploring Mining podcast on iTunes Apple podcasts

Listen to Exploring Mining on Spotify

SilverCrest Metals Inc. (NYSE American:SILV) (TSX:SIL) has announced that its Canadian subsidiary has entered into a credit agreement with an affiliate of RK Mine Finance to provide a secured project financing facility for a total of US$120 million for the purpose of funding the construction of Las Chispas. Additionally, one of the company’s Mexican subsidiaries has entered into a fixed price Engineering, Procurement and Construction (EPC) contract with Ausenco Engineering Canada Inc., and one of its affiliates, for construction of the Las Chispas process plant. SilverCrest CEO N. Eric Fier, said:

"We are very pleased to have concurrently signed the Credit Agreement and the EPC Contract with two well-established and respected partners in the mining industry. The commitment by both partners ahead of the targeted January 2021 release of the Las Chispas Feasibility Study speaks to the strength of our team and project. While we recognize the challenges of building during this unprecedented time, we believe the strict and effective COVID-19 protocols that we have implemented on site, which are highlighted in these two important agreements, limit our risk. This news marks another important milestone on our path to production at Las Chispas."

Agnico Eagle Mines Limited (NYSE:AEM) has entered into an agreement to acquire all of the outstanding common shares of TMAC Resources Inc. (TSX:TMAC). Sean Boyd, Agnico Eagle's Vice-Chairman and CEO, said:

"We are very pleased to have the opportunity to bring our extensive northern operational and community experience to the Hope Bay Mine and the Kitikmeot Region of Nunavut. Together with the TMAC team and our Nunavut partners, we look forward to advancing exploration and expansion initiatives to realize the full potential of the Mine and its large unexplored land package."

Maple Gold Mines Ltd. (TSXV:MGM) has provided an update on exploration activities at its Douay Project in Quebec, Canada. This includes an expansion of the company’s Fall 2020 drill program, comprising 10 holes totalling over 4,000 metres, as well as the commencement of “one of the largest Induced Polarization (IP) surveys to be carried out on the project.” Fred Speidel, VP Exploration for Maple Gold, explained:

"While assay results are taking longer than anticipated to be returned, we made the decision to mobilize a second drill rig to further test this regional anomaly along its full 2-km-long strike length with two additional holes."

Loncor Resources Inc. (TSX:LN) has reported that “the third core hole of a 7,000 metre drilling program at its Adumbi deposit has intersected significant gold intersections of 28.00 metres grading 3.26 g/t gold and 20.30 metres grading 2.83 g/t Au at its 84.68% owned Imbo Project in the eastern part of the Ngayu greenstone belt in the Democratic Republic of the Congo.” Loncor President Peter Cowley commented:

“We are very encouraged by the results of the first three core holes of our 7,000 metre drilling program at Adumbi. All these boreholes have intersected significant widths and grades and should increase the current inferred mineral resource of 2.19 million ounces (28.97 million tonnes grading 2.35 g/t gold) at Adumbi, both within the current open pit and at depth below the pit.”

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Research mining stocks at Investorideas.com with our mining stocks directory at Investorideas.com https://www.investorideas.com/Gold_Stocks/Stocks_List.asp

Disclosure: Investorideas.com is compensated by SilverCrest Metals Inc for annual news publishing More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com to be a guest or sponsor this podcast

800-665-0411

Get more mining stock investor ideas- news, articles, podcasts and stock directories

About Investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/disclosure

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas, Trading Ideas and Stocks to Watch

Wednesday, January 06, 2021

#AIEye #Podcast 504: GBT Tokenize (OTCPINK: $GTCH) Developing Health Analysis Methods Based on Kirlian Electrophotography Research and NICE (NasdaqGS: $NICE) Introduces New #AI-Based RPA Capabilities #artificialintelligence

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

#CryptoCorner #Podcast Episode 502: #Stocks discussed: (OTC: $TGONF) (NYSE: $IGT) (TSXV: $BNXA.V) (OTCQB: $INTV)

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

#MedicalTechnology #Stock Sigyn Therapeutics (OTC: $SIGY) Reports Results of Pilot Study to Address Inflammatory CytoVesicles; @Sigyn_inc

Tuesday, January 05, 2021

#ExploringMining #Podcast Episode 131 – #Mining #Stocks News from (NYSEAmerican: $SILV) (TSX: $SIL.TO) (NYSE: $AEM) (TSX: $TMAC.TO) (TSXV: $MGM.V) (TSX: $LN.TO)

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

Blog Archive

Links

Search This Blog